STOCK TITAN

ClearSign Technologies Appoints G. Todd Silva to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

ClearSign Technologies (Nasdaq: CLIR) has appointed G. Todd Silva to its Board of Directors, effective August 1, 2024. Silva, nominated by clirSPV , brings over 30 years of leadership and finance experience across various industries. He currently serves as the Chief Financial Officer of Radiance Therapeutics, Inc., and has previously held CFO positions at Point Pickup Technologies, Inc. and founded Silva Partnership & Co.

Silva's extensive background includes corporate advisory services, mergers and acquisitions, capital raises, and corporate governance. He holds an MBA from Columbia University and a BS from Lehigh University. ClearSign's CEO, Jim Deller, Ph.D., expressed enthusiasm about Silva joining the board, citing his wealth of experience as valuable for the company's continued expansion and development.

ClearSign Technologies (Nasdaq: CLIR) ha nominato G. Todd Silva nel suo Consiglio di Amministrazione, con effetto dal 1 agosto 2024. Silva, nominato da clirSPV, porta con sé oltre 30 anni di esperienza in posizioni di leadership e finanza in vari settori. Attualmente ricopre il ruolo di Chief Financial Officer presso Radiance Therapeutics, Inc., e in precedenza ha ricoperto posizioni di CFO presso Point Pickup Technologies, Inc. e ha fondato Silva Partnership & Co.

Il vasto bagaglio di esperienze di Silva include servizi di consulenza aziendale, fusioni e acquisizioni, raccolte di capitali e governance aziendale. Ha conseguito un MBA presso la Columbia University e una laurea in scienze presso la Lehigh University. Il CEO di ClearSign, Jim Deller, Ph.D., ha espresso entusiasmo per l'ingresso di Silva nel consiglio, evidenziando la sua ampia esperienza come risorsa preziosa per l'espansione e lo sviluppo continuo dell'azienda.

ClearSign Technologies (Nasdaq: CLIR) ha nombrado a G. Todd Silva en su Junta Directiva, con efecto a partir del 1 de agosto de 2024. Silva, nominado por clirSPV, aporta más de 30 años de experiencia en liderazgo y finanzas en diversas industrias. Actualmente se desempeña como Director Financiero de Radiance Therapeutics, Inc., y previamente ocupó posiciones de CFO en Point Pickup Technologies, Inc. y fundó Silva Partnership & Co.

El extenso historial de Silva incluye servicios de asesoría corporativa, fusiones y adquisiciones, levantamiento de capital y gobernanza corporativa. Tiene un MBA de la Universidad de Columbia y una licenciatura de la Universidad de Lehigh. El CEO de ClearSign, Jim Deller, Ph.D., expresó su entusiasmo por la incorporación de Silva a la Junta, citando su vasta experiencia como un valor añadido para la continua expansión y desarrollo de la empresa.

클리어사인 기술(나스닥: CLIR)이 G. Todd Silva를 이사회에 임명했습니다. 이 효력은 2024년 8월 1일부터 발효됩니다. Silva는 clirSPV의 추천으로 다양한 산업 분야에서 30년 이상의 리더십 및 재무 경험을 가지고 있습니다. 그는 현재 Radiance Therapeutics, Inc.의 최고재무책임자(CFO)로 재직 중이며, 이전에는 Point Pickup Technologies, Inc.에서 CFO로 근무한 경험이 있으며 Silva Partnership & Co.를 설립하였습니다.

Silva의 광범위한 배경에는 기업 자문 서비스, 인수합병, 자본 조달 및 기업 거버넌스가 포함됩니다. 그는 콜롬비아 대학교에서 MBA를, 레하이 대학교에서 학사 학위를 받았습니다. ClearSign의 CEO인 Jim Deller, Ph.D.는 Silva가 이사회에 합류하게 된 것에 대해 열정을 표현하며 그의 풍부한 경험이 회사의 지속적인 확장 및 발전에 소중한 가치가 될 것이라고 언급했습니다.

ClearSign Technologies (Nasdaq: CLIR) a nommé G. Todd Silva au sein de son Conseil d'Administration, avec effet à partir du 1er août 2024. Silva, proposé par clirSPV, apporte plus de 30 ans d'expérience en leadership et en finance dans divers secteurs. Il occupe actuellement le poste de Directeur Financier chez Radiance Therapeutics, Inc. et a précédemment occupé des postes de CFO chez Point Pickup Technologies, Inc. et a fondé Silva Partnership & Co.

Le vaste parcours de Silva comprend des services de conseil aux entreprises, des fusions et acquisitions, des levées de fonds et la gouvernance d'entreprise. Il est titulaire d'un MBA de l'Université de Columbia et d'une licence de l'Université de Lehigh. Le PDG de ClearSign, Jim Deller, Ph.D., a exprimé son enthousiasme quant à l'arrivée de Silva au conseil, soulignant que sa riche expérience serait précieuse pour l'expansion et le développement continus de l'entreprise.

ClearSign Technologies (Nasdaq: CLIR) hat G. Todd Silva in seinen Vorstand berufen, mit Wirkung zum 1. August 2024. Silva, der von clirSPV nominiert wurde, bringt über 30 Jahre Erfahrung in Führung und Finanzen aus verschiedenen Branchen mit. Derzeit ist er als Chief Financial Officer bei Radiance Therapeutics, Inc. tätig und hatte zuvor CFO-Positionen bei Point Pickup Technologies, Inc. inne und gründete die Silva Partnership & Co.

Silvas umfangreicher Hintergrund umfasst Unternehmensberatungsdienste, Fusionen und Übernahmen, Kapitalbeschaffung und Unternehmensführung. Er hat einen MBA von der Columbia University und einen Bachelor-Abschluss von der Lehigh University. Der CEO von ClearSign, Jim Deller, Ph.D., äußerte sich begeistert über Silvas Vorstandseintritt und nannte seine umfassende Erfahrung als wertvoll für die weitere Expansion und Entwicklung des Unternehmens.

Positive
  • Appointment of G. Todd Silva to the Board of Directors, bringing 30+ years of leadership and finance experience
  • Silva's extensive background in corporate advisory services, M&A, and capital raises could benefit CLIR's growth strategies
  • Current CFO experience at Radiance Therapeutics and previous CFO role at Point Pickup Technologies adds valuable financial expertise to the board
Negative
  • None.

TULSA, Okla., Aug. 6, 2024 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, announces that G. Todd Silva has been appointed to serve as a member of the Company's Board of Directors (the "Board"), effective as of August 1, 2024. Mr. Silva was nominated by clirSPV LLC to serve as its director designee.

Mr. Silva brings over 30 years of leadership and finance experience in industries spanning from financial services, technology, health care and others. Mr. Silva has served as the Chief Financial Officer of Radiance Therapeutics, Inc., a development stage medical device company, since April 2023. Prior to this current role, Mr. Silva served as the Chief Financial Officer of Point Pickup Technologies, Inc., a logistics platform service where he worked to consummate and integrate acquisitions, raise capital through various private transactions and assist with corporate governance tasks for their board of directors. Additionally, Mr. Silva was the founder and director of Silva Partnership & Co., a firm providing corporate advisory services to early-stage technology businesses. Prior to Silva Partnership & Co., Mr. Silva was the executive director of corporate advisory services at Las Olas Capital Partners, a registered investment advisor firm where he advised a variety of companies on mergers and acquisitions, capital raises, recapitalizations and the launch of special purpose vehicles to invest in corporate and real estate transactions. Mr. Silva received an MBA from Columbia University focused in finance and accounting and a BS from Lehigh University in economics and finance.

"On behalf of the Company and the Board, I want to welcome Todd to ClearSign," said Jim Deller, Ph.D., Chief Executive Officer of ClearSign. "Todd has a wealth of experience and I look forward to working with him as we continue to expand and develop ClearSign's business."

About ClearSign Technologies Corporation

ClearSign Technologies Corporation designs and develops products and technologies for the purpose of improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety and overall cost-effectiveness. Our patented technologies, embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit www.clearsign.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clearsign-technologies-appoints-g-todd-silva-to-board-of-directors-302213849.html

SOURCE ClearSign Technologies Corporation

FAQ

When did G. Todd Silva join ClearSign Technologies 's (CLIR) Board of Directors?

G. Todd Silva was appointed to ClearSign Technologies 's (CLIR) Board of Directors effective August 1, 2024.

What is G. Todd Silva's current professional role outside of CLIR?

G. Todd Silva currently serves as the Chief Financial Officer of Radiance Therapeutics, Inc., a development stage medical device company, since April 2023.

What relevant experience does G. Todd Silva bring to ClearSign Technologies (CLIR)?

G. Todd Silva brings over 30 years of leadership and finance experience in industries including financial services, technology, and healthcare. He has expertise in mergers and acquisitions, capital raises, and corporate governance.

Who nominated G. Todd Silva to the Board of Directors of ClearSign Technologies (CLIR)?

G. Todd Silva was nominated by clirSPV to serve as its director designee on the Board of Directors of ClearSign Technologies (CLIR).

ClearSign Technologies Corporation

NASDAQ:CLIR

CLIR Rankings

CLIR Latest News

CLIR Stock Data

53.25M
40.15M
20.07%
6.4%
0.53%
Pollution & Treatment Controls
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
TULSA